Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease.

NCT01766960 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT01766960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01766960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease.
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2012
Completion date
June 30, 2014
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver